Literature DB >> 24562969

Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.

John D Robinson1, Christopher D Howard, Elissa D Pastuzyn, Diane L Byers, Kristen A Keefe, Paul A Garris.   

Abstract

Phasic dopamine (DA) signaling, during which burst firing by DA neurons generates short-lived elevations in extracellular DA in terminal fields called DA transients, is implicated in reinforcement learning. Disrupted phasic DA signaling is proposed to link DA depletions and cognitive-behavioral impairment in methamphetamine (METH)-induced neurotoxicity. Here, we further investigated this disruption by assessing effects of METH pretreatment on DA transients elicited by a drug cocktail of raclopride, a D2 DA receptor antagonist, and nomifensine, an inhibitor of the dopamine transporter (DAT). One advantage of this approach is that pharmacological activation provides a large, high-quality data set of transients elicited by endogenous burst firing of DA neurons for analysis of regional differences and neurotoxicity. These pharmacologically evoked DA transients were measured in the dorsomedial (DM) and dorsolateral (DL) striatum of urethane-anesthetized rats by fast-scan cyclic voltammetry. Electrically evoked DA levels were also recorded to quantify DA release and uptake, and DAT binding was determined by means of autoradiography to index DA denervation. Pharmacologically evoked DA transients in intact animals exhibited a greater amplitude and frequency and shorter duration in the DM compared to the DL striatum, despite similar pre- and post-drug assessments of DA release and uptake in both sub-regions as determined from the electrically evoked DA signals. METH pretreatment reduced transient activity. The most prominent effect of METH pretreatment on transients across striatal sub-region was decreased amplitude, which mirrored decreased DAT binding and was accompanied by decreased DA release. Overall, these results identify marked intrastriatal differences in the activity of DA transients that appear independent of presynaptic mechanisms for DA release and uptake and further support disrupted phasic DA signaling mediated by decreased DA release in rats with METH-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24562969      PMCID: PMC4071119          DOI: 10.1007/s12640-014-9459-y

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  85 in total

1.  Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine.

Authors:  Melissa L Barker-Haliski; Katharina Oldenburger; Kristen A Keefe
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

2.  Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.

Authors:  W X Shi; C L Pun; X X Zhang; M D Jones; B S Bunney
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

3.  Pharmacologically induced, subsecond dopamine transients in the caudate-putamen of the anesthetized rat.

Authors:  B Jill Venton; R Mark Wightman
Journal:  Synapse       Date:  2007-01       Impact factor: 2.562

Review 4.  Methamphetamine influences on brain and behavior: unsafe at any speed?

Authors:  John F Marshall; Steven J O'Dell
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

5.  Perseverative behavior in rats with methamphetamine-induced neurotoxicity.

Authors:  Jong-Hyun Son; James Kuhn; Kristen A Keefe
Journal:  Neuropharmacology       Date:  2012-11-14       Impact factor: 5.250

6.  Selective impairment of prediction error signaling in human dorsolateral but not ventral striatum in Parkinson's disease patients: evidence from a model-based fMRI study.

Authors:  Tom Schonberg; John P O'Doherty; Daphna Joel; Rivka Inzelberg; Yoram Segev; Nathaniel D Daw
Journal:  Neuroimage       Date:  2009-08-12       Impact factor: 6.556

7.  Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.

Authors:  Tianxiang Zhang; Lifen Zhang; Yong Liang; Athanassios G Siapas; Fu-Ming Zhou; John A Dani
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

8.  Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.

Authors:  Christopher D Howard; David P Daberkow; Eric S Ramsson; Kristen A Keefe; Paul A Garris
Journal:  Eur J Neurosci       Date:  2013-04-11       Impact factor: 3.386

9.  Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration.

Authors:  Garret D Stuber; Mitchell F Roitman; Paul E M Phillips; Regina M Carelli; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

Review 10.  Behavioral dopamine signals.

Authors:  Wolfram Schultz
Journal:  Trends Neurosci       Date:  2007-04-02       Impact factor: 13.837

View more
  4 in total

1.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

2.  Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats.

Authors:  Genmeng Yang; Liu Liu; Ruilin Zhang; Juan Li; Chi-Kwan Leung; Jian Huang; Yuanyuan Li; Baoyu Shen; Xiaofeng Zeng; Dongxian Zhang
Journal:  Toxicol Res (Camb)       Date:  2020-05-09       Impact factor: 3.524

3.  Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation.

Authors:  Anne S Gibson; Peter J West; Kristen A Keefe
Journal:  Psychopharmacology (Berl)       Date:  2022-01-05       Impact factor: 4.530

4.  Flexible Glassy Carbon Multielectrode Array for In Vivo Multisite Detection of Tonic and Phasic Dopamine Concentrations.

Authors:  Elisa Castagnola; Elaine M Robbins; Bingchen Wu; May Yoon Pwint; Raghav Garg; Tzahi Cohen-Karni; Xinyan Tracy Cui
Journal:  Biosensors (Basel)       Date:  2022-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.